Patients
40.8 % of adults 30–79
High blood pressure (ages 30–79), Malaysia, 2019 (WHO).
Compare every country on the Public Health Dashboard
Updated
Reviewed by Chandani Patel
Malaysia Hypertension Management Devices Market Industry Trends and Forecast to 2034: Segmented by (Product, Channel, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$5.7 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $5.2 Mn | — | — |
| 2025 (base) | $5.6 Mn | +$0.4 Mn | — |
| 2026 (forecast) | $6.1 Mn | +$0.5 Mn | +8.1% |
| 2027 (forecast) | $6.6 Mn | +$0.5 Mn | +16.9% |
| 2028 (forecast) | $7.1 Mn | +$0.5 Mn | +26.3% |
| 2029 (forecast) | $7.7 Mn | +$0.6 Mn | +36.6% |
| 2030 (forecast) | $8.3 Mn | +$0.6 Mn | +47.6% |
| 2031 (forecast) | $9.0 Mn | +$0.7 Mn | +59.6% |
| 2032 (forecast) | $9.7 Mn | +$0.7 Mn | +72.5% |
| 2033 (forecast) | $10.5 Mn | +$0.8 Mn | +86.5% |
| 2034 (forecast) | $11.3 Mn | +$0.8 Mn | +101.6% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $5.6 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $11.3 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 8.1% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, channel and end user (see all) |
| Key players | Omron Healthcare, Withings, A&D Medical, Microlife, Medtronic (see all) |
| Regulator in Malaysia | MDASource: Medical Device Authority. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Hypertension management devices include home blood pressure monitors, connected cuffs and new procedures that help control high blood pressure.
Key segments of the hypertension Management Devices market include product (Home Blood Pressure Monitors, Connected Monitors and Ambulatory Monitors) and channel (Retail, Online and Clinics).
Heart disease remains the leading cause of death worldwide. An ageing population, more minimally invasive procedures and strong clinical evidence for newer devices are driving the hypertension Management Devices market.
Less invasive procedures, remote monitoring of implanted devices and rising access to cardiac care in emerging markets give the hypertension Management Devices market room to grow.
High device prices, the need for trained specialists, reimbursement pressure and product recalls hold back the hypertension Management Devices market.
The hypertension Management Devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Medical devices must be registered with the Medical Device Authority (MDA) under the Medical Device Act 2012.[1] Public clinics and hospitals run by the Ministry of Health give heavily subsidised care.[2] High blood pressure (ages 30–79): 40.8% of adults 30–79 in 2019, the latest WHO figure for Malaysia.[3]
[1] Medical Device Authority. Checked 14 Nov 2026.
[2] Ministry of Health Malaysia. Checked 14 Nov 2026.
[3] WHO Global Health Observatory, High blood pressure (ages 30–79) (% of adults 30–79). Retrieved 21 Nov 2026.
Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how hypertension Management Devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Malaysia.
What doctors and scientists are doing in Hypertension Management Devices right now, from free public sources.
40.8 % of adults 30–79
High blood pressure (ages 30–79), Malaysia, 2019 (WHO).
Compare every country on the Public Health DashboardSources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 21 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] WHO Global Health Observatory, High blood pressure (ages 30–79) (% of adults 30–79). Retrieved 21 Nov 2026.
[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 20 Nov 2026.
[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 21 Nov 2026.
From our blog
Malaysia · 2 shared keywords
Malaysia · 2 shared keywords
Malaysia · 2 shared keywords
Malaysia · 1 shared keyword
Malaysia · 1 shared keyword
Malaysia · 1 shared keyword
Digital Health · Malaysia
Digital Health · Malaysia
Healthcare Services · Malaysia
Digital Health · Malaysia
Healthcare Services · Malaysia
Digital Health · Malaysia